Can Borrelia-specific IgM support recent immune recognition?

Borrelia serology measures host immune recognition, not the presence of living organisms. For a 50-year-old woman, the clinical meaning of an IgM result therefore depends principally on illness timing, compatible syndrome, exposure history, and validated two-tier confirmation.

Clinical interpretation

• Borrelia-specific IgM can support recent immune recognition in an early compatible illness: IgM commonly becomes detectable about 2–4 weeks after infection or symptom onset.
• Its useful diagnostic window is limited. CDC guidance restricts clinical interpretation of IgM to symptoms of ≤30 days; European guidance similarly regards isolated IgM as diagnostically unhelpful in late disease, when an IgG response would generally be expected.
• An isolated IgM-positive/IgG-negative pattern in prolonged symptoms—especially suspected Lyme arthritis—should prompt reconsideration of Lyme disease rather than be treated as evidence of ongoing infection.

Persistence and cross-reactivity

• Persistent IgM is well documented after resolved, treated Lyme disease. In a 10–20-year follow-up of asymptomatic people with prior Lyme disease, IgM remained positive in 10% of those with prior early Lyme disease and 15% with prior Lyme arthritis. Other follow-up found persistence up to 17 months after erythema migrans and 3 years after neuroborreliosis.
• False-positive or borderline Borrelia IgM can arise with EBV, CMV, other viral illnesses, Mycoplasma pneumoniae, rheumatoid arthritis, and other autoimmune conditions; susceptibility varies by assay and clinical context.

Mechanistic and practical implications

• Antibodies can persist after antigen exposure has ended; thus seropositivity does not establish viable organisms. Blood PCR has low diagnostic yield and detects DNA rather than organism viability; even tissue PCR positivity may persist after treatment.
• Bottom line: Borrelia-specific IgM may corroborate recent immune recognition only in an early, clinically compatible presentation. Isolated or late IgM cannot establish ongoing viable infection and is often better explained by persistent antibody responses or cross-reactivity.